Proteomic profiling of HIV-1 infection of human CD4 + T cells identifies PSGL-1 as an HIV restriction factor
Ying Liu,Yajing Fu,Qian Wang,Mushan Li,Zheng Zhou,Deemah Dabbagh,Chunyan Fu,Hang Zhang,Shuo Li,Tengjiang Zhang,Jing Gong,Xiaohui Kong,Weiwei Zhai,Jiaming Su,Jianping Sun,Yonghong Zhang,Xiao-Fang Yu,Zhen Shao,Feng Zhou,Yuntao Wu,Xu Tan
DOI: https://doi.org/10.1038/s41564-019-0372-2
IF: 28.3
2019-01-01
Nature Microbiology
Abstract:Human immunodeficiency virus (HIV) actively modulates the protein stability of host cells to optimize viral replication. To systematically examine this modulation in HIV infection, we used isobaric tag-based mass spectrometry to quantify changes in the abundance of over 14,000 proteins during HIV-1 infection of human primary CD4 + T cells. We identified P-selectin glycoprotein ligand 1 (PSGL-1) as an HIV-1 restriction factor downregulated by HIV-1 Vpu, which binds to PSGL-1 and induces its ubiquitination and degradation through the ubiquitin ligase SCF β-TrCP2 . PSGL-1 is induced by interferon-γ in activated CD4 + T cells to inhibit HIV-1 reverse transcription and potently block viral infectivity by incorporating in progeny virions. This infectivity block is antagonized by Vpu via PSGL-1 degradation. We further show that PSGL-1 knockdown can significantly abolish the anti-HIV activity of interferon-γ in primary CD4 + T cells. Our study identifies an HIV restriction factor and a key mediator of interferon-γ’s anti-HIV activity.